Comment
|
nNOS generates nitric oxide from arginine and in addition hydrogen peroxide (H2O2) and superoxide anion. In the presence of low levels of arginine the formation of superoxide anions in comparison to NO is elevated.
(cited information)
|
Formal Description Interaction-ID: 47189
|
drug/chemical compound
NO
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
nNOS generates nitric oxide from arginine and in addition hydrogen peroxide (H2O2) and superoxide anion. In the presence of low levels of arginine the formation of superoxide anions in comparison to NO is elevated.
(cited information)
|
Formal Description Interaction-ID: 47190
|
drug/chemical compound
O2-
especially in a medium with low arginine concentrations
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
nNOS generates nitric oxide from arginine and in addition hydrogen peroxide (H2O2) and superoxide anion. In the presence of low levels of arginine the formation of superoxide anions in comparison to NO is elevated.
(cited information)
|
Formal Description Interaction-ID: 47191
|
drug/chemical compound
H2O2
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
5HT induces an increase in nNOS activity under conditions where nNOS was shown to produce mainly H2O2 (in the absence of arginine and presence of BH4).
|
Formal Description Interaction-ID: 47196
|
in the absence of arginine
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|